Skip to main content

18. Endoscopic Ablative Therapy

  • Chapter
  • First Online:
  • 2063 Accesses

Abstract

Barrett’s esophagus (BE) results from repeated damage of the esophageal squamous epithelium from gastroesophageal reflux. The defining lesion of BE is specialized intestinal epithelium which is characterized by columnar metaplastic epithelium with goblet cells. BE is a premalignant lesion that progresses to adenocarcinoma at a rate of 0.5% per year. This risk of progression increases with increasing degrees of dysplasia. High-grade dysplasia (HGD) carries the highest risk of developing esophageal adenocarcinoma (EAC) that is 60–125 times that of nondysplastic BE.

The current standard of care for BE with nonvisible HGD is endoscopic ablation. Radiofrequency ablation (RFA) has been found to be safe and effective for the treatment of HGD and can be used in combination with endoscopic mucosal resection for the treatment of superficial (Tis or intramucosal carcinoma and T1a or tumor invade the lamina propria or muscularis mucosae but does not invade the submucosa) EAC. In these clinical settings, the risk of lymph node involvement is low (<4%); thus, localized therapy is effective and can spare patients the morbidity (30%) and mortality (1–2%) of an esophagectomy.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Selected References

  • Barbour AP, Jones M, Brown I, et al. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol. 2010;17: 2494–502.

    Article  PubMed  Google Scholar 

  • Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Tritti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2009.

    Google Scholar 

  • Fernando HC, Murthy SC, Hofstetter W, et al. The society of thoracic surgeons practice guideline series: guidelines for the management of barrett’s esophagus with high-grade dysplasia. Ann Thorac Surg. 2009;87:1993–2002.

    Article  PubMed  Google Scholar 

  • Fleischer DE, Odze R, Overholt BF, et al. The case for endoscopic treatment of ­non-­dysplastic and low-grade dysplastic barrett’s esophagus. Dig Dis Sci. 2010a;55: 1918–31.

    Article  PubMed  Google Scholar 

  • Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation for ­barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010b;42:781–9.

    Article  PubMed  CAS  Google Scholar 

  • Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy. 2008a;40:370–9.

    Article  PubMed  CAS  Google Scholar 

  • Lyday WD, Corbett FS, Kuperman DA, et al. Radiofrequency ablation of barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy. 2010;42:272–8.

    Article  PubMed  CAS  Google Scholar 

  • Pouw RE, Sharma VK, Bergman JJ, Fleischer DE. Radiofrequency ablation for total barrett’s eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy. 2008;40:1033–40.

    Article  PubMed  CAS  Google Scholar 

  • Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010;8:23–9.

    Article  PubMed  Google Scholar 

  • Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.

    Article  PubMed  CAS  Google Scholar 

  • Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007;65:185–95.

    Article  PubMed  Google Scholar 

  • Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242:566–73.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Erin W. Gilbert M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Gilbert, E.W., Hunter, J.G. (2012). 18. Endoscopic Ablative Therapy. In: Nguyen, N., Scott-Conner, C. (eds) The SAGES Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2347-8_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-2347-8_18

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-2346-1

  • Online ISBN: 978-1-4614-2347-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics